Mark Barahman1, Eduardo Grunvald2,3, Pablo J Prado4, Alejandro Bussandri4, Walter C Henderson1, Tanya Wolfson1, Kathryn J Fowler1, Claude B Sirlin1. 1. Liver Imaging Group, Department of Radiology, University of California San Diego, San Diego, California, USA. 2. Division of General Internal Medicine, Department of Medicine, University of California San Diego, San Diego, California, USA. 3. Bariatric and Metabolic Institute, Division of Minimally Invasive Surgery, Department of Surgery, University of California San Diego, San Diego, California, USA. 4. Livivos, San Diego, California, USA.
Abstract
PURPOSE: To assess feasibility and accuracy of point-of-care (POC) NMR-proton density fat fraction (PDFF) in phantoms and in a human pilot study in a POC setting. METHODS: POC NMR (LiverScope, Livivos, San Diego CA) PDFF measurements were obtained of certified phantoms with known PDFF values (0%-40%). In an institutional review board-approved, Health Insurance Portability and Accountability Act-compliant prospective human study, a convenience sample of participants from an obesity clinic was enrolled (November 2020 to June 2021). The inclusion criteria required body mass index (BMI) = 27-40 kg/m2 and willingness to undergo POC NMR and MRI-PDFF measurements. Liver PDFF was measured by POC NMR and, within 35 days after, by a confounder corrected CSE MRI PDFF acquisition and reconstruction method. The adverse events were documented and linear regression analyses were performed. RESULTS: POC NMR-PDFF measurements agreed with known phantom PDFF values (R2 = 0.99). Fourteen participants were enrolled in the pilot human study. MRI-PDFF could not be obtained in 4 participants (claustrophobia reaction, n = 3, exceeded size of MR scanner bore, n = 1). POC NMR was unevaluable in 2 participants (insufficient signal penetration depth, n = 1, failure to comply with instructions, n = 1). Technical success was 11 of 13 (85%) for POC NMR PDFF. In 7 participants (4 female; 31-74 years old; median BMI 35 kg/m2 ), MRI-PDFF (range, 2.8%-18.1%), and POC NMR-PDFF (range, 3%-25.2%), agreed with R2 = 0.94. POC NMR had no adverse events. CONCLUSION: POC NMR measures PDFF accurately in phantoms and, in a first-in-human pilot study, is feasible and accurate in adults with obesity. Further testing to determine precision and accuracy across larger and more diverse cohorts is needed.
PURPOSE: To assess feasibility and accuracy of point-of-care (POC) NMR-proton density fat fraction (PDFF) in phantoms and in a human pilot study in a POC setting. METHODS: POC NMR (LiverScope, Livivos, San Diego CA) PDFF measurements were obtained of certified phantoms with known PDFF values (0%-40%). In an institutional review board-approved, Health Insurance Portability and Accountability Act-compliant prospective human study, a convenience sample of participants from an obesity clinic was enrolled (November 2020 to June 2021). The inclusion criteria required body mass index (BMI) = 27-40 kg/m2 and willingness to undergo POC NMR and MRI-PDFF measurements. Liver PDFF was measured by POC NMR and, within 35 days after, by a confounder corrected CSE MRI PDFF acquisition and reconstruction method. The adverse events were documented and linear regression analyses were performed. RESULTS: POC NMR-PDFF measurements agreed with known phantom PDFF values (R2 = 0.99). Fourteen participants were enrolled in the pilot human study. MRI-PDFF could not be obtained in 4 participants (claustrophobia reaction, n = 3, exceeded size of MR scanner bore, n = 1). POC NMR was unevaluable in 2 participants (insufficient signal penetration depth, n = 1, failure to comply with instructions, n = 1). Technical success was 11 of 13 (85%) for POC NMR PDFF. In 7 participants (4 female; 31-74 years old; median BMI 35 kg/m2 ), MRI-PDFF (range, 2.8%-18.1%), and POC NMR-PDFF (range, 3%-25.2%), agreed with R2 = 0.94. POC NMR had no adverse events. CONCLUSION: POC NMR measures PDFF accurately in phantoms and, in a first-in-human pilot study, is feasible and accurate in adults with obesity. Further testing to determine precision and accuracy across larger and more diverse cohorts is needed.
Authors: Arinc Ozturk; Joseph R Grajo; Michael S Gee; Alex Benjamin; Rebecca E Zubajlo; Kai E Thomenius; Brian W Anthony; Anthony E Samir; Manish Dhyani Journal: Ultrasound Med Biol Date: 2018-09-16 Impact factor: 2.998
Authors: Takeshi Yokoo; Suraj D Serai; Ali Pirasteh; Mustafa R Bashir; Gavin Hamilton; Diego Hernando; Houchun H Hu; Holger Hetterich; Jens-Peter Kühn; Guido M Kukuk; Rohit Loomba; Michael S Middleton; Nancy A Obuchowski; Ji Soo Song; An Tang; Xinhuai Wu; Scott B Reeder; Claude B Sirlin Journal: Radiology Date: 2017-09-11 Impact factor: 11.105
Authors: Diego Hernando; Samir D Sharma; Mounes Aliyari Ghasabeh; Bret D Alvis; Sandeep S Arora; Gavin Hamilton; Li Pan; Jean M Shaffer; Keitaro Sofue; Nikolaus M Szeverenyi; E Brian Welch; Qing Yuan; Mustafa R Bashir; Ihab R Kamel; Mark J Rice; Claude B Sirlin; Takeshi Yokoo; Scott B Reeder Journal: Magn Reson Med Date: 2016-04-15 Impact factor: 4.668
Authors: Gavin Hamilton; Alex N Schlein; Tanya Wolfson; Guilherme M Cunha; Kathryn J Fowler; Michael S Middleton; Rohit Loomba; Claude B Sirlin Journal: NMR Biomed Date: 2020-03-03 Impact factor: 4.044
Authors: Mariana Lazo; Ruben Hernaez; Mark S Eberhardt; Susanne Bonekamp; Ihab Kamel; Eliseo Guallar; Ayman Koteish; Frederick L Brancati; Jeanne M Clark Journal: Am J Epidemiol Date: 2013-05-23 Impact factor: 4.897
Authors: Velicia Bachtiar; Matthew D Kelly; Henry R Wilman; Jaco Jacobs; Rexford Newbould; Catherine J Kelly; Michael L Gyngell; Katherine E Groves; Andy McKay; Amy H Herlihy; Carolina C Fernandes; Mark Halberstadt; Marion Maguire; Naomi Jayaratne; Sophia Linden; Stefan Neubauer; Rajarshi Banerjee Journal: PLoS One Date: 2019-04-10 Impact factor: 3.240
Authors: Andrea Dennis; Matt D Kelly; Carolina Fernandes; Sofia Mouchti; Jonathan A Fallowfield; Gideon Hirschfield; Michael Pavlides; Stephen Harrison; Manu V Chakravarthy; Rajarshi Banerjee; Arun Sanyal Journal: Front Endocrinol (Lausanne) Date: 2021-01-27 Impact factor: 5.555